From: Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma
Metastases | ||||
---|---|---|---|---|
Increased serum S100B | Skin (%) | Regional lymph nodes (%) | Distant visceral (%) | Absent (%) |
Yes | 8 (34.8) | 11 (50.0) | 28 (57.1) | 11 (52.4) |
No | 15 (65.2) | 11 (50.0) | 21 (42.9) | 10 (47.6) |
Total | 23 | 22 | 49 | 21 |